文献速递免疫规划

2009-2019年美国私人保险儿童推荐疫苗接种及时性特征分析

Characterizing timeliness of recommended vaccinations among privately-insured children in the United States, 2009-2019.
PubMed 文献 · Vaccine · 2024-08-07

基于Merative MarketScan商业数据库(2009-2019),纳入至少按时接种一剂2月龄推荐疫苗的婴儿1,239,364名,分析2、4、6、12-15月龄同时接种推荐疫苗剂次数及累积接种率。4月龄婴儿28%、6月龄婴儿38%未及时同时接种全部推荐疫苗;既往延迟接种者后续剂次接种时间更长。所有研究疫苗剂次全国覆盖率随时间改善,以麻腮风疫苗最明显,但许多儿童未按推荐程序接种,需早期干预维持接种依从性。

要点

  • 4月龄婴儿28%、6月龄婴儿38%未及时同时接种全部推荐疫苗。
  • 既往延迟接种者后续剂次接种时间持续更长。
  • 所有研究疫苗剂次覆盖率随时间改善,麻腮风最明显。

核心结论

  • 所有研究疫苗剂次全国覆盖率随时间改善,以麻腮风疫苗最明显,但许多儿童未按推荐程序接种,需早期干预维持接种依从性。

研究设计与样本

  • 利用Merative MarketScan商业数据库(2009-2019),识别至少按时接种一剂2月龄推荐疫苗的私人保险婴儿1,239,364名。
  • 按2、4、6、12-15月龄窗口(宽限期-7、+21天)统计同日接种推荐疫苗剂次数,用桑基图展示同时接种剂次数及随时间状态转换,并估计每种疫苗剂次的累积接种率。

主要发现

  • 1,239,364名合格儿童中,4月龄婴儿28%、6月龄婴儿38%未及时同时接种全部推荐疫苗。
  • 第二年开始推荐接种的剂次,其及时同时接种的疫苗剂次数和接种年龄变异最大。
  • 既往延迟接种(相对于及时接种)的儿童,后续剂次接种时间持续更长。

关键数值与推荐

  • 2、4、6、12-15月龄接种窗口的宽限期为-7、+21天。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Advisory Committee on Immunization Practices (ACIP) recommends early childhood vaccinations, but knowledge is limited about the magnitude and timing of vaccine delay for each recommended dose on a population level. We sought to characterize longitudinal patient-level patterns of early childhood vaccination schedule adherence. METHODS: Using the Merative MarketScan Commercial Database (2009-2019), we identified commercially-insured infants who received at least one timely dose of a 2-month recommended vaccine. We categorized the number of recommended vaccines administered on the same date at 2, 4, 6, and 12-15 months of age (grace period: -7, +21 days). A Sankey diagram illustrated the number of vaccines received concomitantly during each age window and depicted transitions to different states over time (e.g., no vaccine delay to vaccine delay). For each vaccine dose, we estimated the cumulative incidence of receipt. RESULTS: Among 1,239,364 eligible children, 28% of infants aged 4 months and 38% of infants aged 6 months did not receive timely, concomitant administration of all recommended vaccines. The number of timely vaccines received concomitantly and age at receipt varied most for doses recommended during the second year of life. Children with a previously delayed (versus timely) dose consistently experienced longer time to subsequent dose. CONCLUSIONS: National coverage improved over time for all recommended vaccine doses under study, most notably for measles, mumps, and rubella. However, many children do not receive vaccines on schedule. Interventions to maintain adherence to the recommended schedule are needed early in life.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Butler AM, Newland JG, Sahrmann JM, et al. Characterizing timeliness of recommended vaccinations among privately-insured children in the United States, 2009-2019. Vaccine. 2024. PMID: 39116485. doi:10.1016/j.vaccine.2024.126179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。